瑞凝生物

Biotech/Healthcare

Ruining Biotechnology is an emerging medical hydrogel company. Based on its proprietary, first-of-its-kind ready-to-use PEG hydrogel material, it provides clinical solutions for radiotherapy protection, wound repair, tumor embolization, and innovative anticancer drugs.

Latest round: Series C (2026)